PubRank

V R McCready

Author PubWeight™ 82.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 1983 1.73
2 Grey scale echography in the diagnosis of intrahepatic disease. J Clin Ultrasound 1973 1.71
3 Ultrasound and scintigraphy in the differential diagnosis of obstructive jaundice. J Clin Ultrasound 1974 1.70
4 FDG accumulation and tumor biology. Nucl Med Biol 1998 1.59
5 The potential of intratumoural unsealed radioactive source therapy. Eur J Nucl Med 2001 1.49
6 Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med Mol Imaging 2002 1.45
7 Physical test for distant metastases in patients with breast cancer. J R Soc Med 1980 1.42
8 31P-NMR studies of a human tumour in situ. Lancet 1983 1.27
9 Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed 1998 1.27
10 In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet 1989 1.18
11 Clinical radioisotope scanning. Br J Radiol 1967 1.16
12 Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology 1976 1.15
13 Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet 1983 1.12
14 False positive 131I whole body scans in thyroid cancer. Br J Radiol 2000 1.11
15 Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984 1.10
16 Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996 1.09
17 A co-ordinate transfer system for the Pho Gamma 3 Nuclear Chicago gamma camera. Br J Radiol 1969 1.09
18 Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab 1986 1.03
19 The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma. Br J Obstet Gynaecol 1989 1.01
20 The non-invasive monitoring of low dose, infusional 5-fluorouracil and its modulation by interferon-alpha using in vivo 19F magnetic resonance spectroscopy in patients with colorectal cancer: a pilot study. Ann Oncol 1993 0.99
21 Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol 1989 0.98
22 Combined pancreas and liver scanning using a double isotope technique. Br J Radiol 1971 0.98
23 High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. Br J Cancer 2002 0.98
24 62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med 2001 0.96
25 A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer 1991 0.95
26 The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol 1977 0.94
27 Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed 1994 0.94
28 A constant depth ultrasonic scanner. Br J Radiol 1971 0.94
29 The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 1998 0.93
30 Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet 1983 0.92
31 The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma. Br J Cancer 1989 0.91
32 Scintigraphic studies of space-occupying liver disease. Semin Nucl Med 1972 0.91
33 Thyroid cancer: differentiated carcinoma. Cancer Treat Rev 1996 0.91
34 The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol 1990 0.91
35 99mTc-HMPAO as a tumour blood flow agent. Eur J Nucl Med 1987 0.89
36 Tumour imaging radiopharmaceuticals. Br J Radiol 1975 0.88
37 Measurement of radiation dose to the thyroid using positron emission tomography. Br J Radiol 1987 0.88
38 Three-dimensional display of data obtained by single photon emission computed tomography. Br J Radiol 1987 0.88
39 Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol 1980 0.88
40 Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med 1997 0.87
41 A clinical evaluation of grey-scale ultrasonography. Br J Radiol 1976 0.87
42 Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours. Br J Cancer 1989 0.87
43 A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. Eur J Nucl Med Mol Imaging 2006 0.86
44 Clinical tests on a prototype semiconductor gamma-camera. Br J Radiol 1971 0.85
45 A pulse generator for use with the Picker MagnaScanner colour printer. Br J Radiol 1967 0.85
46 Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol 1996 0.84
47 Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy. Eur J Nucl Med 1994 0.84
48 Radioimmunoscintigraphy of squamous carcinomas of the head and neck. Head Neck Surg 1987 0.84
49 Low-dose 131I in treatment of Graves' disease. J R Soc Med 1985 0.83
50 Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases. Br J Cancer 2001 0.83
51 Spleen scanning. Proc R Soc Med 1969 0.83
52 HM-PAO assessment of human tumour perfusion. Eur J Cancer Clin Oncol 1987 0.83
53 The use of 18-F for bone scanning. Br J Radiol 1967 0.83
54 Thyroid cancer: a review of treatment and follow-up. Ann Nucl Med 1996 0.82
55 A comparision of grey-scale ultrasound with other methods for the detection of liver metastases from breast carcinoma. Clin Oncol 1976 0.81
56 99Tcm-labelled meso-HMPAO and glutathione content of human lung tumours. Nucl Med Commun 1989 0.79
57 An evaluation of 99mTc-HMPAO uptake in cerebral gliomas--a comparison with X-ray CT. Eur J Nucl Med 1990 0.79
58 Demonstration of blood flow patterns in human soft tissue sarcomas using 99mTc-labelled hexamethyl propyleneamineoxime. Br J Surg 1990 0.79
59 Initial experience with Tc-99m-HM-PAO in the study of brain tumors. Eur J Nucl Med 1988 0.79
60 The stability and distribution of Tc-HIDA in vivo and in vitro. Eur J Nucl Med 1979 0.78
61 Effects of cellular repair and proliferation on targeted radionuclide therapy: a modelling study. Phys Med Biol 2000 0.78
62 The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies. Br J Radiol 1983 0.78
63 Thyroid imaging using positron emission tomography--a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis. Br J Radiol 1990 0.77
64 The effect of chelating agents on the distribution of monoclonal antibodies in mice. J Nucl Med 1986 0.77
65 Cellular versus vascular rejection in transplant kidneys. Correlation of radionuclide and Doppler studies with histology. Nucl Med Commun 1993 0.77
66 Detection of increased blood flow to the affected arm in repetitive strain injury with radionuclide and Doppler ultrasound studies. A case report. Clin Nucl Med 1995 0.77
67 99Tcm-MDP blood-pool phase in the assessment of repetitive strain injury. Nucl Med Commun 1997 0.77
68 The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed 1991 0.77
69 Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma. Eur J Nucl Med 1995 0.77
70 Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol 1998 0.77
71 A different approach to the use of unsealed radionuclides for cancer therapy. Eur J Nucl Med 1995 0.77
72 2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation. Anticancer Res 1998 0.76
73 An antibody-desferrioxamine conjugate labelled with 67Ga. Int J Rad Appl Instrum B 1986 0.76
74 An unusually high nasal uptake of radioactive iodine during treatment for carcinoma of the thyroid. Am J Roentgenol Radium Ther Nucl Med 1966 0.76
75 Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid. Radiother Oncol 1989 0.76
76 Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management. Eur J Nucl Med 1995 0.76
77 Clinical isotope scanning using 67 Ga citrate in the management of Hodgkin's disease. Br J Radiol 1972 0.76
78 Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol 1993 0.76
79 Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with (131)I. Br J Radiol 2001 0.75
80 Phosphocholine and choline content of rat sarcoma cells grown in the presence and absence of serum. Anticancer Res 1996 0.75
81 Radionuclide therapy dose calculations: what accuracy can be achieved? Eur J Nucl Med 1997 0.75
82 A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease. Eur J Cancer 1992 0.75
83 The appearance of the pyramidal lobe on thyroid scintigraphy. Nucl Med Commun 1984 0.75
84 Comparison of radioisotope and ultrasound scans of the thyroid. Proc R Soc Med 1975 0.75
85 Value of gallium scanning in seminoma of the testis. Br Med J 1976 0.75
86 Clinical applications of isotopes in diagnosis and research. Proc R Soc Med 1966 0.75
87 Liver diseases and liver tumours from the diagnostic point of view. Radioisotope methods. Proc R Soc Med 1974 0.75
88 Diagnosis of liver metastases using ultrasound and isotope scanning techniques. J R Soc Med 1978 0.75
89 Pancreas scanning using a double isotope technique. Proc R Soc Med 1971 0.75
90 Low-dose radioiodine given six-monthly in Graves' disease. J R Soc Med 1985 0.75
91 The gamma camera in malignant disease. Proc R Soc Med 1972 0.75
92 Uptake of gallium-67 in colonic and rectal tumours. Br Med J 1972 0.75
93 Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen. Br J Cancer 1993 0.75
94 Role of ultrasound in the management of ovarian carcinoma. J R Soc Med 1983 0.75
95 The use of 131I-MIBG in the imaging of metastatic carcinoid tumours. Br J Cancer 1988 0.75
96 Visualisation of tumours using labelled antibodies. Br J Radiol 1984 0.75
97 Bone changes in adult acute leukaemia. Br J Radiol 1968 0.75
98 Accuracy of grey-scale ultrasonography of liver and spleen in Hodgkin's disease and the other lymphomas compared with isotope scans. Clin Radiol 1977 0.75
99 Proceedings: Radioisotope localization of the placenta. Br J Radiol 1974 0.75
100 Renal involvement with non-Hodgkin's lymphoma: investigation of a recent case. Br J Radiol 1978 0.75
101 The place of diagnostic isotopes in the radiotherapy department. Br J Radiol 1969 0.75
102 Differential isotope scanning of the brain employing an electronic ratio-subtract technique. Strahlentherapie Sonderb 1968 0.75
103 The concentration of 67Ga and 45Ca in the lactating mammary gland and its relevance to the tumor uptake of 67Ga citrate. Cancer Res 1976 0.75
104 The comparative values of investigating the thorax by arteriographic and scanning techniques with particular reference to pulmonary embolism. Br J Radiol 1969 0.75
105 Becquerel's legacy to nuclear medicine. Eur J Nucl Med 1996 0.75
106 Tumour localization. Br Med Bull 1980 0.75
107 The use of the gamma camera and rectilinear scanning for demonstrating organs other than the kidney. Br J Urol 1969 0.75
108 Emission tomographic scanning. Radiobiol Radiother (Berl) 1981 0.75
109 Failure of iodine-131 MIBG imaging in small cell lung carcinoma. J Nucl Med 1987 0.75
110 A clinician's appraisal. Br J Radiol 1970 0.75
111 A clinical evaluation of a prototype positron camera for longitudinal emission tomography. Br J Radiol 1984 0.75
112 The use of the renogram in obstructive uropathy due to pelvic tumours. Nucl Med (Stuttg) 1970 0.75
113 Visualisation of mediastinal lymph nodes by scintillation scanning. Indian J Cancer 1967 0.75
114 Ultrasonography of Hodgkin's disease in the liver and spleen. Clin Radiol 1982 0.75
115 The effect of oestrogen ablation on the phospholipid metabolite content of primary and transplanted rat mammary tumours. NMR Biomed 1993 0.75
116 The doughnut sign in patients with multiple myeloma. Nucl Med Commun 1986 0.75
117 The future of PET. Nucl Med Commun 1989 0.75
118 Clinical applications of SPECT with special reference to oncology. Acta Med Port 1989 0.75
119 Blood flow measurement in extremity soft tissue sarcoma with technetium-99m hexamethyl-propyleneamineoxime and single photon emission computed tomography. Br J Surg 1994 0.75
120 Isotopes in clinical diagnosis. Curr Med Drugs 1967 0.75
121 Organ visualization using radioactive isotopes. Practitioner 1971 0.75
122 Anatomically derived attenuation coefficients for use in quantitative single photon emission tomography studies of the thorax. Eur J Nucl Med 1992 0.75
123 Single photon emission computed tomographic imaging and volume estimation of the thyroid using fan-beam geometry. Br J Radiol 1986 0.75
124 Clinical applications of gamma camera tomography. Br J Radiol 1973 0.75
125 Radioisotopes in the diagnosis of thyroid carcinoma. Monogr Neoplast Dis Var Sites 1970 0.75
126 Diagnostic aspects of thyroid carcinoma. Br J Radiol 1971 0.75
127 Scanning: which technique? Br J Hosp Med 1979 0.75
128 The B-scan ultrasonic appearances of gas in the biliary tree. Br J Radiol 1978 0.75
129 3D positron emission tomography: preliminary results. Br J Radiol 1986 0.75
130 Comparison of 5-fluorouracil pharmacokinetics following intraperitoneal and intravenous administration using in vivo 19F magnetic resonance spectroscopy. Br J Radiol 1990 0.75
131 Ultrasound tomography of the liver: Non-invasive method of choice for the differential diagnosis of jaundice. Aust N Z J Med 1978 0.75
132 Colour DOPPLER image analysis for tissue vascularity and perfusion: a preliminary clinical evaluation. Ultrasound Med Biol 1995 0.75
133 Indium (111In)-labelled bleomycin for the detection of intracranial lesions. Nucl Med (Stuttg) 1975 0.75
134 Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate. Eur J Nucl Med 1995 0.75
135 The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT. Eur J Nucl Med 1985 0.75
136 Constant depth ultrasonic scanning. Br J Radiol 1973 0.75
137 Ultrasonographic evaluation of hepatic metastases in testicular tumour. Br J Radiol 1982 0.75
138 Portable profile scanning apparatus for detection of deep venous thrombosis in the leg. Lancet 1971 0.75
139 Proceedings: The current status of gallium 67 scanning. Br J Radiol 1975 0.75
140 The preoperative detection of axillary lymph node metastases in breast cancer by isotope imaging. Br J Surg 1983 0.75
141 Reversible findings of methylene diphosphonate bone scintigraphy in Raynaud's phenomenon: case report and review of the literature. Eur J Nucl Med 1994 0.75
142 The diaphragmatic echo complex: an in vitro study. Invest Radiol 1985 0.75
143 Some aspects of studies relating to pancreas scanning. Br J Radiol 1971 0.75
144 Preliminary clinical images from a prototype positron camera. Br J Radiol 1983 0.75
145 Ultrasound scanning. Nurs Mirror Midwives J 1977 0.75
146 A comparison between 180 degrees and 360 degrees data reconstruction in single photon emission computed tomography of the liver and spleen. Br J Radiol 1983 0.75
147 Digital and analogue processing of radioisotope scans. Br J Radiol 1971 0.75
148 The role of radionuclide studies in breast cancer. Nucl Med Commun 1993 0.75
149 Quantitative single-photon emission tomography for tumour blood flow measurement in bronchial carcinoma. Eur J Nucl Med 1993 0.75
150 Clinical applications of SPECT with special reference to oncology. Acta Med Port 1989 0.75
151 The urinary excretion of gallium-67 citrate in patients with neoplastic disease. Eur J Nucl Med 1979 0.75
152 The uptake of gallium 67 in colonic macrophages. Eur J Nucl Med 1976 0.75
153 Proceedings: The assessment of abdominal lymph-nodes with ultrasound. Br J Radiol 1976 0.75
154 Processing nuclear medicine records. Phys Med Biol 1973 0.75
155 The chemical form of gallium-67 in urine. Int J Nucl Med Biol 1978 0.75
156 Immunoscintigraphy of colorectal cancer using a monoclonal antibody 77-1. Eur J Surg Oncol 1991 0.75
157 Blood transfusions and blood sampling during red blood cell mean life span determinations. Eur J Nucl Med 2000 0.75
158 New techniques of hard copy production from the gamma camera. Strahlentherapie Sonderb 1975 0.75
159 A clinical comparison of the tumour-imaging radiopharmaceuticals 67Gallium-citrate and 111Indium-labelled bleomycin. Br J Radiol 1975 0.75
160 Spleen scanning using a double isotope technique. Br J Radiol 1971 0.75